Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.9M Buy
193,922
+151,034
+352% +$14.2M 0.07% 297
2026
Q1
$5.07M Buy
42,888
+1,574
+4% +$195K 0.03% 631
2025
Q4
$5.2M Buy
41,314
+23,658
+134% +$3.09M 0.09% 243
2025
Q3
$2.58M Buy
17,656
+4,493
+34% +$679K 0.03% 786
2025
Q2
$2.05M Buy
13,163
+1,870
+17% +$297K 0.02% 810
2025
Q1
$1.86M Buy
11,293
+657
+6% +$109K 0.03% 778
2024
Q4
$1.73M Sell
10,636
-6,316
-37% -$1.13M 0.03% 791
2024
Q3
$3.31M Buy
16,952
+8,058
+91% +$1.48M 0.05% 497
2024
Q2
$1.54M Buy
8,894
+877
+11% +$146K 0.03% 706
2024
Q1
$1.36M Buy
8,017
+1,671
+26% +$313K 0.02% 741
2023
Q4
$1.25M Buy
6,346
+901
+17% +$160K 0.03% 677
2023
Q3
$947K Buy
5,445
+1,006
+23% +$183K 0.03% 684
2023
Q2
$764K Buy
4,439
+1,677
+61% +$290K 0.03% 690
2023
Q1
$460K Buy
+2,762
New +$453K 0.03% 408

Other funds holding ZTS

Empowered Funds's ZTS Position: Q2 2026 in Review

Empowered Funds increased its Zoetis (ZTS) stake by 352% in Q2 2026, buying an estimated $14.2M and bringing the position to 193,922 shares worth $13.9M. The position accounts for 0.07% of the portfolio, ranked #297.

Empowered Funds first reported a position in ZTS in Q1 2023 and has held it in 14 quarters since. 1,427 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Empowered Funds held 193,922 shares of Zoetis worth $13.9M as of Q2 2026.
  • Empowered Funds bought 151,034 Zoetis shares in Q2 2026, an estimated $14.2M.
  • Zoetis made up 0.07% of Empowered Funds's portfolio in Q2 2026, its #297 holding.
  • Empowered Funds first reported a position in Zoetis in Q1 2023 and has held it in 14 quarters since.
  • 1,427 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.